1. Violi, F. et al. The ADA (Age-D-Dimer-Albumin) Score to Predict Thrombosis in SARS-CoV-2. Thromb Haemost. 2022;122(9):1567–1572. doi: 10.1055/a-1788-7592. Epub 2022 Mar 4.
2. Malgaj Vrečko, M., Aleš Rigler, A. & Večerić-Haler, Ž. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review. Int J Mol Sci. 2022;23(19):11307. doi: 10.3390/ijms231911307.
3. Thondapu, V. et al. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord. 2021;9(4):835–844.e4. doi: 10.1016/j.jvsv.2020.11.006. Epub 2020 Nov 12.
4. Jenner, W.J. & Gorog, D.A. Incidence of thrombotic complications in COVID-19: On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium. J Thromb Thrombolysis. 2021;52(4):999–1006. doi: 10.1007/s11239-021-02475-7. Epub 2021 May 28.
5. Abou-Ismail, M.Y., Diamond, A., Kapoor, S., Arafah, Y. & Nayak, L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020 Oct:194:101–115. doi: 10.1016/j.thromres.2020.06.029. Epub 2020 Jun 20.